Economy / Labor
U.S. jobless claims fall to 197,000 as job growth stays modest
New applications slipped by 2,000, while continuing claims rose. The weekly figures complement September’s modest gain in payroll employment.
Desk byline
TickerGrove Newsroom
TickerGrove's source-backed editorial desk covering companies, filings, earnings, markets, macroeconomics, ETFs, and financially relevant developments.
TickerGrove Newsroom uses AI-assisted newsroom workflows. Reporting is built from source-backed research and passes TickerGrove sourcing, verification, editorial, and quality controls before publication.
Named bylines identify editorial desks, not independent human reporters.
This byline identifies TickerGrove Newsroom reporting, checked against primary sources and dated evidence.
TickerGrove Newsroom · How TickerGrove checks a claim · Corrections
Economy / Labor
New applications slipped by 2,000, while continuing claims rose. The weekly figures complement September’s modest gain in payroll employment.
Healthcare / M&A
Viatris will pay $36.50 a share in cash — about 45% above Wednesday's close — for the maker of Exparel and Zilretta, assembling a non-opioid pain franchise ahead of a December FDA decision on its meloxicam candidate.
Markets / AI Financing
Apollo and Blackstone are among the lenders Broadcom has approached to fund its OpenAI chip collaboration; Oracle is in talks with Apollo and Goldman Sachs on a large chip purchase — the AI buildout is outgrowing bonds.
Energy / M&A
The $2.625 billion cash-and-stock deal adds Vaquero's 300-mile Delaware Basin gathering network and the 675 MMcf/d Caymus processing complex to Energy Transfer's Permian footprint, with closing expected in the fourth quarter.
AI / Capital Raise
Bloomberg reports DeepSeek is set to secure at least 80 billion yuan — possibly 100 billion — with Tencent and CATL writing some of the largest checks, as the AI company builds a war chest ahead of a domestic listing.
Trade / MedTech
BD will invest $19 billion in the U.S. over several years — $3 billion for strategic manufacturing sites — in exchange for shelter from future Section 232 tariffs. It's the first major American medtech company to cut a deal like this.
Earnings / Turnaround
Revenue rose 6.5% to $222.8 million and adjusted earnings of $0.08 a share topped the $0.05 consensus. The company lifted its fiscal 2027 outlook, repaid $30 million of term debt, and is moving Petrifilm production in-house.
Earnings / AI
Adjusted earnings of $1.00 a share topped the $0.77 consensus and revenue hit a record $567 million. Integrated memory sales jumped 158% — and the fiscal 2027 guide implies roughly 40% revenue growth.